Deal Library / Pharma BD Deal Intelligence

Sanofi-Aventis — Pharma Deals

The Pharma Closeout tracks 4 deals, $5.6B in disclosed deal value, 4 with a post-close Outcome Score for Sanofi-Aventis.

Median Critic Score: 69  ·  Median Outcome Score: 44

Best outcome: Sanofi-Aventis / Symbion Consumer (Primary Health Care) (71)  ·  Weakest outcome: Sanofi-Aventis / BiPar Sciences, Inc. (8)

All 4 deals

• Sanofi-Aventis / Symbion Consumer (Primary Health Care) — 2008 · $544M · Largely worked — most objectives met.
• Sanofi-Aventis / Merial Limited (Merck's 50% interest) — 2009 · $4.0B · Largely worked — most objectives met.
• Sanofi-Aventis / Fovea Pharmaceuticals SA — 2009 · $541M · Did not work — the deal failed to deliver.
• Sanofi-Aventis / BiPar Sciences, Inc. — 2009 · $500M · Did not work — the deal failed to deliver.

← Deal Library  ·  Interactive search  ·  How we score deals